{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:37:56Z","timestamp":1761597476464},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.canlet.2013.12.027","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T08:01:20Z","timestamp":1388736080000},"page":"237-248","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Murine Pten\u2212\/\u2212 T-ALL requires non-redundant PI3K\/mTOR and DLL4\/Notch1 signals for maintenance and \u03b3c\/TCR signals for thymic exit"],"prefix":"10.1016","volume":"346","author":[{"given":"Thijs J.","family":"Hagenbeek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Choy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryll","family":"Sanchez-Irizarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somasekar","family":"Seshagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian W.","family":"Siebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2013.12.027_b0005","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.175.5.2783","article-title":"Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase","volume":"175","author":"Webb","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2013.12.027_b0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","article-title":"Deficient T cell fate specification in mice with an induced inactivation of Notch1","volume":"10","author":"Radtke","year":"1999","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.canlet.2013.12.027_b0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20040495","article-title":"The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling","volume":"200","author":"Hagenbeek","year":"2004","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.canlet.2013.12.027_b0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.leu.2405056","article-title":"T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus","volume":"22","author":"Hagenbeek","year":"2008","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.canlet.2013.12.027_b0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.leu.2404255","article-title":"Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia","volume":"20","author":"Weerkamp","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.canlet.2013.12.027_b0030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"issue":"5694","key":"10.1016\/j.canlet.2013.12.027_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.canlet.2013.12.027_b0040","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"O\u2019Neil","year":"2007","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.canlet.2013.12.027_b0045","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood-2009-07-235143","article-title":"Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia","volume":"115","author":"Sanda","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.canlet.2013.12.027_b0050","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1158\/0008-5472.CAN-05-3830","article-title":"Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53","volume":"66","author":"Mungamuri","year":"2006","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2013.12.027_b0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.canlet.2013.12.027_b0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2009-04-214718","article-title":"Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A\/ARF loss","volume":"115","author":"Medyouf","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2013.12.027_b0065","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.186.8.1269","article-title":"Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules","volume":"186","author":"Kirberg","year":"1997","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.canlet.2013.12.027_b0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.186.9.1597","article-title":"Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3","volume":"186","author":"Heemskerk","year":"1997","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.canlet.2013.12.027_b0075","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V94.8.2637.420k22_2637_2646","article-title":"Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3","volume":"94","author":"Jaleco","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canlet.2013.12.027_b0080","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2005-05-2090","article-title":"Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B","volume":"107","author":"Dontje","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.canlet.2013.12.027_b0085","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/hum.1996.7.12-1405","article-title":"Episomal vectors rapidly and stably produce high-titer recombinant retrovirus","volume":"7","author":"Kinsella","year":"1996","journal-title":"Hum. Gene Ther."},{"issue":"7122","key":"10.1016\/j.canlet.2013.12.027_b0090","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nature05313","article-title":"Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis","volume":"444","author":"Ridgway","year":"2006","journal-title":"Nature"},{"issue":"7291","key":"10.1016\/j.canlet.2013.12.027_b0095","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2013.12.027_b0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.22.012703.104721","article-title":"Phosphoinositide 3-kinase: diverse roles in immune cell activation","volume":"22","author":"Deane","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2013.12.027_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2004.00203.x","article-title":"Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways","volume":"202","author":"Kovanen","year":"2004","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.canlet.2013.12.027_b0110","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.4049\/jimmunol.178.9.5443","article-title":"Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition","volume":"178","author":"Mao","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2013.12.027_b0115","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood.V98.5.1524","article-title":"Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1)","volume":"98","author":"Barata","year":"2001","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.canlet.2013.12.027_b0120","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1158\/0008-5472.CAN-10-3606","article-title":"IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2013.12.027_b0125","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/emboj\/17.7.1871","article-title":"The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages","volume":"17","author":"Haks","year":"1998","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.canlet.2013.12.027_b0130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Pear","year":"1996","journal-title":"J. Exp. Med."},{"issue":"20","key":"10.1016\/j.canlet.2013.12.027_b0135","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1128\/MCB.20.20.7505-7515.2000","article-title":"Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1","volume":"20","author":"Aster","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2013.12.027_b0140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL","volume":"107","author":"O\u2019Neil","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.canlet.2013.12.027_b0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.20061442","article-title":"Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation","volume":"204","author":"Besseyrias","year":"2007","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.canlet.2013.12.027_b0150","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1084\/jem.20080829","article-title":"Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment","volume":"205","author":"Koch","year":"2008","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.canlet.2013.12.027_b0155","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1084\/jem.20080134","article-title":"Delta-like 4 is indispensable in thymic environment specific for T cell development","volume":"205","author":"Hozumi","year":"2008","journal-title":"J. Exp. Med."},{"issue":"25","key":"10.1016\/j.canlet.2013.12.027_b0160","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1182\/blood-2010-05-286328","article-title":"Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1","volume":"116","author":"Ashworth","year":"2010","journal-title":"Blood"},{"issue":"3 Pt 1","key":"10.1016\/j.canlet.2013.12.027_b0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1078-0432.CCR-05-1654","article-title":"Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase\/Akt\/mammalian target of rapamycin pathway","volume":"12","author":"Granville","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2013.12.027_b0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Brit. J. Haematol."},{"issue":"8","key":"10.1016\/j.canlet.2013.12.027_b0175","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V99.8.2977","article-title":"The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes","volume":"99","author":"Till","year":"2002","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.canlet.2013.12.027_b0180","first-page":"6469","article-title":"Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia","volume":"63","author":"Qiuping","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2013.12.027_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35095500","article-title":"Lymphostromal interactions in thymic development and function","volume":"1","author":"Anderson","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2013.12.027_b0190","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood.V88.3.970.970","article-title":"Modulated expression of notch1 during thymocyte development","volume":"88","author":"Hasserjian","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2013.12.027_b0195","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","article-title":"Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development","volume":"18","author":"Saito","year":"2003","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.canlet.2013.12.027_b0200","doi-asserted-by":"crossref","first-page":"e6678","DOI":"10.1371\/journal.pone.0006678","article-title":"Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes","volume":"4","author":"Dudley","year":"2009","journal-title":"PLoS One"},{"issue":"7354","key":"10.1016\/j.canlet.2013.12.027_b0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.canlet.2013.12.027_b0210","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of Notch1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.canlet.2013.12.027_b0215","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1096\/fasebj.14.7.895","article-title":"Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo","volume":"14","author":"Borlado","year":"2000","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.canlet.2013.12.027_b0220","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.4049\/jimmunol.170.9.4475","article-title":"Phosphatidylinositol 3-kinase regulates the CD4\/CD8 T cell differentiation ratio","volume":"170","author":"Rodriguez-Borlado","year":"2003","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.canlet.2013.12.027_b0225","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1182\/blood-2005-08-3300","article-title":"Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival","volume":"107","author":"Swat","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.canlet.2013.12.027_b0230","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4049\/jimmunol.174.3.1230","article-title":"Phosphatidylinositol 3-kinase regulates thymic exit","volume":"174","author":"Barbee","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2013.12.027_b0235","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ni.1603","article-title":"Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking","volume":"9","author":"Sinclair","year":"2008","journal-title":"Nat. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513008653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513008653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T08:11:31Z","timestamp":1597306291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383513008653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0304383513008653"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.12.027","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine Pten\u2212\/\u2212 T-ALL requires non-redundant PI3K\/mTOR and DLL4\/Notch1 signals for maintenance and \u03b3c\/TCR signals for thymic exit","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2013.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}